Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ie-Ming Shih

Showing results (251-260 of 364) with videos related to

Pageof 37
Sort By:
The American Journal of Pathology|March 26, 2011
Somatic mutations of PPP2R1A in ovarian and uterine carcinomasIe-Ming Shih, Pradeep K Panuganti, Kuan-Tin Kuo, et al.
Bioinformatics (Oxford, England)|February 8, 2011
DDN: a caBIG® analytical tool for differential network analysisBai Zhang, Ye Tian, Lu Jin, et al.
Nature Communications|October 19, 2017
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinomaJennifer Ducie, Fanny Dao, Michael Considine, et al.
The Journal of Pathology|August 16, 2021
Mutation and methylation profiles of ectopic and eutopic endometrial tissuesLihong Li, Maria Facadio Antero, Ming Zhang, et al.
Human Pathology|September 2, 2014
ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladderSheila F Faraj, Alcides Chaux, Nilda Gonzalez-Roibon, et al.
Ebiomedicine|September 8, 2019
Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancerYu Yu, Yohan Suryo Rahmanto, Yao-An Shen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 15, 2012
Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinomaAyse Ayhan, Tsui-Lien Mao, Tamer Seckin, et al.
The Journal of Pathology|December 17, 2013
Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancyRen-Chin Wu, Ayse Ayhan, Daichi Maeda, et al.
Scientific Reports|May 23, 2023
Establishment of a novel model of endometriosis-associated ovarian cancer by transplanting uterine tissue from Arid1a/Pten knockout miceMotoki Ono, Tsutomu Miyamoto, Ryoichi Asaka, et al.
The American Journal of Surgical Pathology|March 18, 2011
Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinomaBin Guan, Tsui-Lien Mao, Pradeep K Panuganti, et al.
Pageof 37

Showing results (251-260 of 364) with videos related to

Sort By:
Pageof 37
The American Journal of Pathology|March 26, 2011
Somatic mutations of PPP2R1A in ovarian and uterine carcinomasIe-Ming Shih, Pradeep K Panuganti, Kuan-Tin Kuo, et al.
Bioinformatics (Oxford, England)|February 8, 2011
DDN: a caBIG® analytical tool for differential network analysisBai Zhang, Ye Tian, Lu Jin, et al.
Nature Communications|October 19, 2017
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinomaJennifer Ducie, Fanny Dao, Michael Considine, et al.
The Journal of Pathology|August 16, 2021
Mutation and methylation profiles of ectopic and eutopic endometrial tissuesLihong Li, Maria Facadio Antero, Ming Zhang, et al.
Human Pathology|September 2, 2014
ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladderSheila F Faraj, Alcides Chaux, Nilda Gonzalez-Roibon, et al.
Ebiomedicine|September 8, 2019
Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancerYu Yu, Yohan Suryo Rahmanto, Yao-An Shen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 15, 2012
Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinomaAyse Ayhan, Tsui-Lien Mao, Tamer Seckin, et al.
The Journal of Pathology|December 17, 2013
Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancyRen-Chin Wu, Ayse Ayhan, Daichi Maeda, et al.
Scientific Reports|May 23, 2023
Establishment of a novel model of endometriosis-associated ovarian cancer by transplanting uterine tissue from Arid1a/Pten knockout miceMotoki Ono, Tsutomu Miyamoto, Ryoichi Asaka, et al.
The American Journal of Surgical Pathology|March 18, 2011
Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinomaBin Guan, Tsui-Lien Mao, Pradeep K Panuganti, et al.
Pageof 37